| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 03/01/2007 | WO2007024858A1 Method and apparatus for measuring the crepe of a moving sheet |
| 03/01/2007 | WO2007024825A2 Immunoaffinity separation and analysis compositions and methods |
| 03/01/2007 | WO2007024763A2 Industrial field device with automatic indication of solids |
| 03/01/2007 | WO2007024735A2 Method and antibodies for detecting nitrofuran |
| 03/01/2007 | WO2007024700A2 Exendin for treating diabetes and reducing body weight |
| 03/01/2007 | WO2007024678A2 Scintillation proximity assay for the identification of p-glycoprotein modulators |
| 03/01/2007 | WO2007024661A2 Precise measurement of red blood cells in a blood sample |
| 03/01/2007 | WO2007024633A2 Multi-directional immunochromatographic assays |
| 03/01/2007 | WO2007024597A2 System for detecting multiple different targets in a sample |
| 03/01/2007 | WO2007024589A2 Phagocyte enhancement therapy for atherosclerosis |
| 03/01/2007 | WO2007024368A2 Compositions and methods to control angiogenesis with cupredoxins |
| 03/01/2007 | WO2007024272A2 Cartridge with a wheel for sealing the opening |
| 03/01/2007 | WO2007024249A2 Engineering fc antibody regions to confer effector function |
| 03/01/2007 | WO2007024185A1 Preparing biological samples for analysis |
| 03/01/2007 | WO2007024014A1 Method of measuring interaction between molecules and measurement apparatus using the method |
| 03/01/2007 | WO2007023915A1 Imprint polymer and use thereof |
| 03/01/2007 | WO2007023876A1 Method for differential analysis on amounts of substance contained in multiple samples |
| 03/01/2007 | WO2007023808A1 Skin aging marker and technique for use thereof |
| 03/01/2007 | WO2007023628A1 Secretory antigen 1 protein of babesia gibsoni, dna encoding the same and use thereof |
| 03/01/2007 | WO2007023431A1 Substrate material for handling and analyzing samples |
| 03/01/2007 | WO2007023430A1 Substrate material for handling and analysing samples |
| 03/01/2007 | WO2007023372A2 Analyte assaying by means of immunochromatography with lateral migration |
| 03/01/2007 | WO2007023316A2 Assay for trypanosome infection |
| 03/01/2007 | WO2007023297A1 Method |
| 03/01/2007 | WO2007023282A1 Use of holographic sensor |
| 03/01/2007 | WO2007023204A1 Device for measuring the hydraulic conductivity of xylem |
| 03/01/2007 | WO2007023191A2 Polypeptide marker for the diagnosis of bladder cancer |
| 03/01/2007 | WO2007023184A1 System for screening cells for high expression of a protein of interest (poi) |
| 03/01/2007 | WO2007022940A1 In vitro method for diagnosing and monitoring renal cell carcinoma (rcc) using mmp-7 as humoral biomarker for rcc |
| 03/01/2007 | WO2007022668A1 Important lymphocyte activation regulatory protein pkd2 and uses thereof |
| 03/01/2007 | WO2007022625A1 Peptide reversion methods and uses thereof |
| 03/01/2007 | WO2007022588A1 Method for assessing a response to an antiproliferative agent |
| 03/01/2007 | WO2007022557A1 Mimotopes of epstein-barr virus (ebv) epitopes |
| 03/01/2007 | WO2007008071A3 Method for detecting peptides comprising a cross-beta structure |
| 03/01/2007 | WO2007006864A3 Method for evaluating cell populations |
| 03/01/2007 | WO2007005666A3 System and method of analyte detection using differential receptors |
| 03/01/2007 | WO2007000169A3 Non-human mammalian arthritis model featuring human antibodies against citrullinated proteins |
| 03/01/2007 | WO2006137052A3 Uniformly conjugated serine hydrolases |
| 03/01/2007 | WO2006136392A3 Novel genes and proteins of brachyspira pilosicoli and use of same for diagnosis and therapy |
| 03/01/2007 | WO2006135893A3 Methods for diagnosing and treating cerebrovascular events based on nr2 peptides |
| 03/01/2007 | WO2006134305A3 Method for screening anticancer substances, set or kit for implementing said method |
| 03/01/2007 | WO2006133460A3 Methods for diagnosing and treating breast cancer based on a her/er ratio |
| 03/01/2007 | WO2006133408A3 Breast cancer and prostate cancer assessment |
| 03/01/2007 | WO2006133399A9 METHOD FOR PREDICTING IMMUNE RESPONSE TO NEOPLASTIC DISEASE BASED ON mRNA EXPRESSION PROFILE IN NEOPLASTIC CELLS AND STIMULATED LEUKOCYTES |
| 03/01/2007 | WO2006132983A3 Differential expression of molecules associated with vascular disease risk |
| 03/01/2007 | WO2006132953A3 Solar-powered integrated-diagnostic instrument |
| 03/01/2007 | WO2006128082A3 Biomarkers for breast cancer |
| 03/01/2007 | WO2006127966A3 Compositions and methods for enhancing axon regeneration |
| 03/01/2007 | WO2006125446A3 Quantification of the viability of lactic acid bacteria using flow cytometry |
| 03/01/2007 | WO2006125176A8 Microsystem spectroscopy |
| 03/01/2007 | WO2006119497A3 Acetylycholine gated ion channel chaperons and methods of using the same |
| 03/01/2007 | WO2006119456A3 Methods and compositions for treating toxoplasma |
| 03/01/2007 | WO2006117672A3 Detection of ortho-diamine residues in analytes containing residual cyclizing agents |
| 03/01/2007 | WO2006113220A9 Transgenic mammals expressing human preproinsulin |
| 03/01/2007 | WO2006110589A8 Gammaretrovirus associated with cancer |
| 03/01/2007 | WO2006103334A3 Method for analyzing a blood sample and apparatus and reagent for implementing said method |
| 03/01/2007 | WO2006094194A3 Fluorous-based microarrays |
| 03/01/2007 | WO2006091729A3 Revascularization of ischemic retinal tissue and screening method therefor |
| 03/01/2007 | WO2006086799A3 Prion-specific peptide reagents |
| 03/01/2007 | WO2006086730A3 Inhibiting her2 shedding with matrix metalloprotease antagonists |
| 03/01/2007 | WO2006084471A3 Method of rational drug design based on binding ability with elongation factor tu |
| 03/01/2007 | WO2006084466A3 Surface-located streptococcus pneumoniae polypeptides |
| 03/01/2007 | WO2006073442A3 Detection of nuclear weapons and fissile material aboard cargo containerships |
| 03/01/2007 | WO2006060653A3 Lung cancer prognostics |
| 03/01/2007 | WO2006053110A3 Ovr110 antibody compositions and methods of use |
| 03/01/2007 | WO2006026557A3 Methods and kits for predicting risk for peterm labor |
| 03/01/2007 | WO2006020567A3 Method for diagnosing obstructive sleep apnea |
| 03/01/2007 | WO2006012646A3 Amacr cancer markers |
| 03/01/2007 | WO2005124341A3 Stable isotope labeled polypeptide standards for protein quantitation |
| 03/01/2007 | WO2005119255A3 Constrained cis-diol-borate bioconjugation system |
| 03/01/2007 | WO2005119244A9 Peptide modulators of cellular phenotype and bi-nucleic acid fragment library |
| 03/01/2007 | WO2005111243A3 Multiplexed detection of biological agents |
| 03/01/2007 | WO2005017120A3 Mracs as modifiers of the rac pathway and methods of use |
| 03/01/2007 | WO2005017107A3 Specific binding agents to hepatocyte growth factor |
| 03/01/2007 | WO2004096977A3 Crystal structure of homo sapiens adipocyte lipid binding protein and uses thereof |
| 03/01/2007 | WO2004081180A3 Crystals and structures of ephrin reception epha7 |
| 03/01/2007 | WO2004081032A3 Novel litaf binding site peptides and methods of using the same |
| 03/01/2007 | WO2004046343A3 Polynucleotide sequence detection assays and analysis |
| 03/01/2007 | WO2004045369A3 Nuclear receptor-based diagnostic, therapeutic, and screening methods |
| 03/01/2007 | WO2003086277A3 Attenuated gram negative bacteria |
| 03/01/2007 | US20070050858 Inactive ca2+/calmodulin-dependent protein kinase II-alpha knockin animal and knockin cell of the same |
| 03/01/2007 | US20070050148 Activity evaluation method for evaluation target compound |
| 03/01/2007 | US20070049736 Cytokine receptor specific immunoglobulin for prevention and treatment of infection, cell proliferative and autoimmune disorders |
| 03/01/2007 | US20070049539 Rsk inhibitors and therapeutic uses thereof |
| 03/01/2007 | US20070049532 Selecting by phage display a peptide that binds to nerve growth factor (NGF), and preparing a fusion protein with an Fc domain; biological half-life increases |
| 03/01/2007 | US20070049526 using Zven1 and Zven2 polypeptides to increase chemokine production for treating intestinal motility disorders and improving gastrointestinal funciton |
| 03/01/2007 | US20070048878 Diagnostic sanitary test strip |
| 03/01/2007 | US20070048875 Method and system for testing and controlling a custody of a fluid specimen |
| 03/01/2007 | US20070048874 Processing and analysis techniques involving in-vessel material generation |
| 03/01/2007 | US20070048873 Method of quantitative analysis of hexavalent chromium in chromate coating |
| 03/01/2007 | US20070048872 High throughput screening of fatty acid composition |
| 03/01/2007 | US20070048871 Test strip with adsorbent affixed to backing is spotted with polar indicator of Solvent blue 45 or ESTOFIL BLUE S-RLS; oil sample is positioned on heat conducting device supporting test strip and is allowed to migrate over adsorbent; displacement is correlated to amount of polar compounds in sample |
| 03/01/2007 | US20070048846 Detecting ligands that stimulate the proliferation and/or development of hematopoietic, lymphoid and myeloid cells |
| 03/01/2007 | US20070048841 Viricidal polypeptide for prevention and treatment of hepatitis infection |
| 03/01/2007 | US20070048822 activating tyrosine phosphorylation of ErbB4 in an ErbB4-expressing cell by administering to the cell a polypeptide comprising the amino acid sequence of neuregulin 3 |
| 03/01/2007 | US20070048820 Methods for assaying inhibition of HIV-1 envelope glycoprotein-mediated membrane fusion |
| 03/01/2007 | US20070048811 Tumor suppressor designated TS10q23.3 |
| 03/01/2007 | US20070048810 ATP-binding cassette protein responsible for cytotoxin resistance |
| 03/01/2007 | US20070048809 Using monoclonal antibody NUH2 as diagnositic tool in identifying cell proliferative disorders of urogenital system in individual negative for prostate specific antigen |
| 03/01/2007 | US20070048808 Hepatocellular carcinoma screening |